Responsive image

Common name


N-(p-tolyl)methanesulfonamide

IUPAC name


N-(p-tolyl)methanesulfonamide

SMILES


Cc1ccc(cc1)NS(=O)(=O)C

Common name


N-(p-tolyl)methanesulfonamide

IUPAC name


N-(p-tolyl)methanesulfonamide

SMILES


Cc1ccc(cc1)NS(=O)(=O)C

INCHI


InChI=1S/C8H11NO2S/c1-7-3-5-8(6-4-7)9-12(2,10)11/h3-6,9H,1-2H3

FORMULA


C8H11NO2S

Responsive image

Common name


N-(p-tolyl)methanesulfonamide

IUPAC name


N-(p-tolyl)methanesulfonamide





Molecular weight


185.243

clogP


0.795

clogS


-2.544

Frequency


0.0003





HBond Acceptor


2

HBond Donor


1

Total Polar
Surface Area


46.17

Number of Rings


1

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00092 Dofetilide Responsive image Anti-Arrhythmia Agents; Potassium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class III; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; CYP3A4 Inhibitors; For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4mk8_ligand_2_20.mol2 4mk8 1 -6.63 Cc1ccc(cc1)NS(=O)(=O)C 12
2o5k_ligand_2_14.mol2 2o5k 1 -6.06 c1(ccc(cc1)NS(=O)(=O)C)C 12
3exo_ligand_1_1.mol2 3exo 0.897436 -6.94 N(S(=O)(=O)C)c1c(cccc1)C 12
1w0y_ligand_2_15.mol2 1w0y 0.897436 -5.90 c1(c(cccc1)NS(=O)(=O)C)C 12
5bml_ligand_2_0.mol2 5bml 0.875 -6.57 Cc1cccc(NS(=O)(=O)C)c1 12
4mk8_ligand_3_34.mol2 4mk8 0.857143 -6.75 CCc1ccc(cc1)NS(=O)(=O)C 13
2o5k_ligand_3_19.mol2 2o5k 0.857143 -6.23 CCc1ccc(cc1)NS(=O)(=O)C 13
4lsj_ligand_1_2.mol2 4lsj 0.805556 -6.96 N(S(=O)(=O)C)c1ccccc1 11
4mk8_ligand_1_6.mol2 4mk8 0.805556 -6.47 c1ccc(cc1)NS(=O)(=O)C 11
4hxs_ligand_2_3.mol2 4hxs 0.805556 -6.42 c1(ccccc1)NS(=O)(=O)C 11
101 , 11